<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04398186</url>
  </required_header>
  <id_info>
    <org_study_id>GiresunU</org_study_id>
    <nct_id>NCT04398186</nct_id>
  </id_info>
  <brief_title>The Effect of Polycystic Ovary Syndrome on Pelvic Floor Structure and Function</brief_title>
  <official_title>The Effect of Polycystic Ovary Syndrome on Pelvic Floor Structure and Function</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Giresun University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Giresun University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Polycystic Ovarian Syndrome (PCOS) is the most common endocrinological disorder in women of
      reproductive age, and its prevalence is reported to be 6-21% in women aged 15-49 (1).
      Although its etiopathogenesis is still not clear, it is known that it is due to the
      disregulation of ovarian steroidogenesis under the influence of some environmental and
      genetic factors. Diagnosis of ESHRE / ASRM has set Rotterdam criteria in 2003; one of these
      criteria is the presence of hyperandrogenism (2). Hyperandrogenism leads to an increase in
      general muscle mass in the body (1, 3, 4).

      Pelvic floor muscles are associated with urethra in the anterior compartment, rectum and anus
      in the posterior compartment, and uterine support in the apex; major urinary and fecal
      continence ensuring its functions in order to stop in the appropriate position of the pelvic
      organs (5). The well-being of the pelvic floor muscle strength has a protective effect from
      urinary and fecal incontinence.

      It has been emphasized that the &quot;anogenital distance&quot; determined by the measurement of the
      anal region anterior to the clitoris anterior may also be a criteria in the diagnosis of
      Polycystic Ovary Syndrome (7,8,9).

      In this study, patients in the reproductive age between 18-40 years, who applied to our
      gynecology outpatient clinic and were diagnosed as PCOS according to Rotterdam criteria wil
      be study gorup and the women without PCOS will be control group. We aimed to evaluate the
      pelvic muscle strength with perineometry, to measure anogenital distance and to determine
      possible relationships with each other. In addition to demographic information, ICIQ-SF
      (Urinary incontinence inquiry short form) will also be taken to evaluate pelvic floor
      function (10).
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 1, 2020</start_date>
  <completion_date type="Anticipated">November 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">October 1, 2020</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>6 Months</target_duration>
  <primary_outcome>
    <measure>Anogenital distance measurement in PCOS</measure>
    <time_frame>01.06.2020- 01.11.2020</time_frame>
  </primary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Reproductive System Disorder</condition>
  <condition>Urinary Incontinence</condition>
  <condition>Urogenital Disease</condition>
  <condition>Polycystic Ovary Syndrome</condition>
  <arm_group>
    <arm_group_label>Study group 1</arm_group_label>
    <description>Hiperandrogenism + ultrasonographic PCO</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Study group 2</arm_group_label>
    <description>Menstruel cycle irregular + ultrasonographic PCO</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Study group 3</arm_group_label>
    <description>Menstruel cycle irregular + ultrasonographic PCO + hyperandrogenism</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <description>Do not have PCOS</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Anogenital distance measurement</intervention_name>
    <description>Measurements of AGD and perineal muscle strength</description>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_label>Study group 1</arm_group_label>
    <arm_group_label>Study group 2</arm_group_label>
    <arm_group_label>Study group 3</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Reproductive aged females, age between 18-40 yrs.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Nulliparity

        Exclusion Criteria:

          -  Endocrine disorders

          -  Anabolic drug usage Multiparity
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Reproductive aged females</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>sebnem alanya tosun, Ass. prof.</last_name>
    <phone>00905325758395</phone>
    <email>sebnem_alanya@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>alptekin tosun, Prof</last_name>
    <phone>00905062398361</phone>
    <email>tosun_alptekin@yahoo.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Sebnem Alanya Tosun</name>
      <address>
        <city>Giresun</city>
        <zip>28100</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>sebnem a tosun</last_name>
      <phone>00905325758395</phone>
      <email>sebnem_alanya@hotmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>May 18, 2020</study_first_submitted>
  <study_first_submitted_qc>May 18, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 21, 2020</study_first_posted>
  <last_update_submitted>June 18, 2020</last_update_submitted>
  <last_update_submitted_qc>June 18, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 22, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Giresun University</investigator_affiliation>
    <investigator_full_name>Sebnem Alanya Tosun</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>polycystic ovary syndrome</keyword>
  <keyword>urinary incontinence</keyword>
  <keyword>anogenital distance</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Polycystic Ovary Syndrome</mesh_term>
    <mesh_term>Urinary Incontinence</mesh_term>
    <mesh_term>Enuresis</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

